SG Americas Securities, LLC
Broker-DealerPosition in RIGL — Rigel Pharmaceuticals Inc
CIK 1313360
NEW YORK, NY
Position in RIGL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$129,721
-$240,375 QoQ
Shares Held
3,316
-75.8% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#103
of 156 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. RIGL ranks #149 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in RIGL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129,721 | 3,316 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $370,096 | 13,687 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $546,853 | 12,768 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $198,706 | 7,014 | Shares | Sole | 2025-10-23 | |
| 2025-03-31 | $106,680 | 5,930 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $158,595 | 9,429 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $106,820 | 6,602 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $130,689 | 15,899 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $32,839 | 22,189 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $72,025 | 49,673 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $34,012 | 31,493 | Shares | Sole | 2023-10-13 | |
| 2023-03-31 | $197,697 | 149,771 | Shares | Sole | 2023-04-28 | |
| 2022-09-30 | $120,428 | 102,058 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $223,977 | 198,210 | Shares | Sole | 2022-07-29 | |
| 2021-12-31 | $77,663 | 29,307 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $298,658 | 82,275 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $55,361 | 12,756 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $129,310 | 37,810 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,527,575 | 436,450 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $183,789 | 76,579 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $21,092 | 11,526 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $220,217 | 141,165 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||